REG - Informa PLC - Transaction in Own Shares

InformaAnnouncement

10/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230210:nRSJ5041Pa&default-theme=true

RNS Number : 5041P  Informa PLC  10 February 2023

Informa PLC Press Release

10 February 2023

Informa Share Buyback Programme

Update on GAP 2 shareholder returns

Informa (LSE: INF.L), the international Academic Markets, B2B Markets and
Digital Services Group today provided an update on its Share Buyback Programme
that forms part of the 2021-2024 Growth Acceleration Plan 2 ('GAP 2').

Share Buyback Programme

GAP 2 is Informa's four-year programme to create a more focused, higher growth
business. This includes accelerated investment in its two businesses with
scale leadership positions, B2B Markets and Academic Markets, and the
divestment of its Informa Intelligence portfolio of businesses.

GAP 2 also includes a commitment to accelerate shareholder returns, sharing
some of the divestment proceeds with shareholders, alongside increased
investment into the Group's two leadership businesses. This led to the
resumption of ordinary dividends and a £725m Share Buyback Programme.

As part of this Share Buyback, on 09 February 2023, the Company purchased
292,554 ordinary shares for cancellation through Morgan Stanley & Co.
International plc at an average price of 679.66 pence per share. The highest
and lowest purchase price paid per share were 681.60 and 677.00 respectively,
with the aggregate details of shares purchased by trading venue as outlined in
the table below:

 Trading venue          Weighted average price paid per share (GBp)  Aggregate number of shares purchased  Lowest price paid per share  Highest price paid per share

(GBp)
(GBp)
 London Stock Exchange  679.71                                       92,922                                677.00                       681.20
 Chi-X (CXE)            679.64                                       142,536                               677.20                       681.60
 BATS (BXE)             679.74                                       40,261                                677.40                       681.20
 AQUIS (AQXE)           679.45                                       16,835                                677.80                       680.80

Following settlement of the above purchases and cancellation of the purchased
ordinary shares, the Company's total number of ordinary shares in issue, and
its total voting rights, will be 1,412,892,719 ordinary shares.  The Company
does not hold any shares in Treasury.

Through the period of Informa's close period (30 days from 6 February to 8
March 2023 inclusive), Morgan Stanley & Co. International plc will make
trading decisions in relation to the Company's securities independently of the
Company. Any share purchases during this period will be undertaken within
certain pre-set parameters and in accordance with the Company's general
authority to repurchase shares, Chapter 12 of the Listing Rules and Article
5(1)(b) of Regulation (EU) No 596/2014 (the 'Market Abuse Regulation').

In accordance with Article 5(1)(b) of the Market Abuse Regulation, a full
breakdown of the individual trades made as part of the buyback programme is
detailed in the attachment.

http://www.rns-pdf.londonstockexchange.com/rns/5041P_1-2023-2-9.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/5041P_1-2023-2-9.pdf)

 Enquiries
 Richard Menzies-Gow, Director of IR & Communications      +44 (0) 20 8052 2787
 Heledd Hanscomb, Deputy Company Secretary                 +44 (0) 20 8052 0661

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSBRGDDGBGDGXC